Your browser doesn't support javascript.
Therapy Targets SARS-CoV-2 Infection-Induced Cell Death.
Zhu, Zhoujie; Shi, Jiayi; Li, Long; Wang, Jinling; Zhao, Yufen; Ma, Huabin.
  • Zhu Z; Institute of Drug Discovery Technology, Ningbo University, Ningbo, China.
  • Shi J; Institute of Drug Discovery Technology, Ningbo University, Ningbo, China.
  • Li L; Institute of Drug Discovery Technology, Ningbo University, Ningbo, China.
  • Wang J; Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Ningbo University, Ningbo, China.
  • Zhao Y; School of Medicine, Xiamen University, Xiamen, China.
  • Ma H; Institute of Drug Discovery Technology, Ningbo University, Ningbo, China.
Front Immunol ; 13: 870216, 2022.
Article in English | MEDLINE | ID: covidwho-1875413
ABSTRACT
Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global health issue. The clinical presentation of COVID-19 is highly variable, ranging from asymptomatic and mild disease to severe. However, the mechanisms for the high mortality induced by SARS-CoV-2 infection are still not well understood. Recent studies have indicated that the cytokine storm might play an essential role in the disease progression in patients with COVID-19, which is characterized by the uncontrolled release of cytokines and chemokines leading to acute respiratory distress syndrome (ARDS), multi-organ failure, and even death. Cell death, especially, inflammatory cell death, might be the initiation of a cytokine storm caused by SARS-CoV-2 infection. This review summarizes the forms of cell death caused by SARS-CoV-2 in vivo or in vitro and elaborates on the dedication of apoptosis, necroptosis, NETosis, pyroptosis of syncytia, and even SARS-CoV-2 E proteins forming channel induced cell death, providing insights into targets on the cell death pathway for the treatment of COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.870216

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Distress Syndrome / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.870216